Australia's largest stock trading and investment forum Australia's #1 stock forum

GXY

Click for more information

0.00%

$5.28 galaxy resources limited

Ann: Strategy Briefing Day, page-35

First 35 Last

Share
Profile

Follow
nexus451

253 Posts.

41

08/11/19

14:36

Post #: 41322840
Share

Originally posted by yanlin: ↑

"The VA will issue a report to creditors on the 21st and will likely include proposals for them to vote on the following 28th Nov"

If that is the case, then the strong inference is that Bald Hill (and perhaps a share of Cowan) will become part of GXY and that our strategy day is when Simon announces to the world what a 2 x Oz spod mine + 1 x Argentine brine mine + 1 x Nth American integrated chemical conversion strategy will look like. There might even be a China chemical converter bolt on thrown in for good measure (and diversity)??

I'm guessing that GXY is about to get bigger - and during a time in the market that's in (short term) turmoil.

I say, Bravo to the Board & management of GXY!!!

PS hey Joe Lowry, are you watching this??

Expand

I agree @yanlin Bravo. I have been disappointed and critical of the gxy management team for poor communication of company strategic direction and information to shareholders / broader market (outside of obligations for quarterly/agm’s). I really like the direction the company has decided to go with this announcement. I look forward to hearing and seeing what is presented!

GXY Price at posting: $1.07 Sentiment: Hold Disclosure: Held
14 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 179 more messages in this thread...

First 35 Last

Add GXY (ASX) to my watchlist